Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 202-211 , April 2005

Predicting the development of diabetic nephropathy and its progression

  • Josette William
    • ,
  • Donn Hogan
    • ,
  • Daniel Batlle

      Affiliations

    • Corresponding Author InformationAddress correspondence to Daniel Batlle, MD, Division of Nephrology/Hypertension, Northwestern University, Feinberg School of Medicine, Searle Building 10-475, 303 East Chicago Avenue, Chicago, IL 60611-3008.

References 

  1. Amos A , McCarthy D , Zimmet P . The rising global burden of diabetes and its complications (Estimates and projections to the year 2010) . Diabetes Med . 1997;14(Suppl 5):S1–S85 (suppl 5)
  2. King H , Aubert R , Herman W . Global burden of diabetes 1995-2025. Prevalence, numerical estimates and projections . Diabetes Care . 1998;21:1414–1431
  3. Batlle D . Clinical and cellular markers of diabetic nephropathy . Kidney Int . 2003;63:2319–2330
  4. Mogyorosi A , Ziyadeh FN . Update on pathogenesis, markers and management of diabetic nephropathy . Curr Opin Nephrol Hypertens . 1996;5:243–253
  5. Moorthi KMLST , Lurbe E , Redon J , et al.   Nocturnal hypertension (Is it important to control nighttime blood pressure to prevent progression of diabetic renal disease?) . Hypertension Rep . 2004;6:393–399
  6. Keane WF , Brenner BM , DeZeeuw D , et al.   The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy (The RENAAL study) . Kidney Int . 2003;36:1499–1507
  7. Parving HH . Diabetic nephropathy (Prevention and treatment) . Kidney Int . 2001;60:2041–2055
  8. Remuzzi G , Ruggenenti P , Perico N . Chronic renal diseases (Renal protective benefits of renin-angiotensin system inhibition) . Ann Intern Med . 2002;136:604–615
  9. DeZeeuw D , Remuzzi G , Parving HH , et al.   Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy (Lessons from RENAAL Kidney International) . Kidney Int . 2004;65:2309–2320
  10. Remuzzi G , Bertani T . Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? . Kidney Int . 1990;38:384–394
  11. Lewis EJ , Hunsicker LG , Bain RP , et al.   The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy . N Engl J Med . 1993;329:1456–1462
  12. Maschio G , Alberti D , Janin G , et al.   Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency . N Engl J Med . 1996;334:939–945
  13. Breyer JA , Bain P , Evans JK , et al.   Predictors of the progression of renal insufficiency in patients with insulin dependent diabetes and over diabetic nephropathy . Kidney Int . 1996;50:1651–1658
  14. Rossing P , Hommel E , Smidt UM , et al.   Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment . Diabetologia . 1994;37:511–516
  15. Fioretto P , Steffes MW , Barbosa J , et al.   Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs . Diabetes . 1999;48:865–869
  16. Quinn M , Angelico MC , Warram JH , et al.   Familial factors determine the development of diabetic nephropathy in patients with IDDM . Diabetologia . 1996;39:940–945
  17. Seaquist ER , Goetz FC , Rich S , et al.   Familial clustering of diabetic kidney disease . N Engl J Med . 1989;320:1161–1165
  18. The Diabetes Control and Complications Trial Research Group . Clustering of long term complications in families with diabetes in the diabetes control and complications trials . Diabetes . 1997;46:1829–1839
  19. Borch-Johnsen K , Norgaard K , Hommel E , et al.   Is diabetic nephropathy an inherited complication? . Kidney Int . 1992;41:719–722
  20. Krolewski AS , Canessa M , Warram JA , et al.   Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus . N Engl J Med . 1988;1988:140–145
  21. Viberti GC , Keen H , Wiseman MJ . Raised arterial pressure in parents of proteinuric insulin dependent diabetes . Br J Med . 1987;295:515–517
  22. Brazilay J , Warram JH , Bak M , et al.   Predisposition to hypertension (Risk factors for nephropathy and hypertension in IDDM) . Kidney Int . 1992;41:723–730
  23. Earle K , Viberti GC , Walker J , et al.   Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy . N Engl J Med . 1992;326:673–677
  24. Yip J , Mattock MB , Morocutti A , et al.   Insulin resistance in insulin-dependent diabetic patients with MA . Lancet . 1993;342:883–887
  25. Mogensen CE , Christensen CK . Predicting diabetes in insulin-dependent patients . N Engl J Med . 1984;311:89–93
  26. Parving HH , Oxenboll B , Tacons J , et al.   Early detection of patients at risk of developing diabetic nephropathy (A longitudinal study of urinary albumin excretion) . Acta Endocrinol . 1982;100:550–555
  27. Viberti GC , Hill RD , Jarrett RJ , et al.   Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus . Lancet . 1982;1:1430–1432
  28. Bangstand HJ , Osterby R , Dahl-Jorgensen K , et al.   Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with MA . Diabetologia . 1993;36:523–529
  29. Chavers BM , Bilous RW , Ellis EN , et al.   Glomerular lesions and urinary albumin excretion in type 1 diabetic patients without overt proteinuria . N Engl J Med . 1989;320:966–970
  30. Fioretto P , Steffes MW , Mauer M . Glomerular structure in nonproteinuric insulin-dependent diabetic patients with various levels of albuminuria . Diabetes . 1994;43:1358–1364
  31. Caramori ML , Fioretto P , Mauer M . The need for early predictors of diabetic nephropathy risk (Is albumin excretion rate sufficient?) . Diabetes . 2000;49:1399–1408
  32. Bain SC , Chowdhury TA . Genetics of diabetic nephropathy and microalbuminuria . J R Soc Med . 2000;93:62–66
  33. de Leeuw PW , van Leeuwen SJ , Birkenhanger WH . Effect of sleep on blood pressure and correlates . Clin Exp Hypertens . 1985;7:179–186
  34. Forsblom CM , Groop PH , Ekstrand A , et al.   Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration . Br J Med . 1992;305:1051–1053
  35. Rundberg S , Persson B , Dahlquist G . Increased glomerular filtration rate as a predictor of diabetic nephropathy . Kidney Int . 1992;41:822–828
  36. The Diabetes Control and Complications Trial Research Group . Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial . Kidney Int . 1995;47:1703–1720
  37. The ACE Inhibitors IN Diabetic Nephropathy Trialist Group . Should all type 1 diabetic microalbuminuric patients receive ACE inhibitors? . A meta-regression analysis Ann Intern Med . 2001;134:370–379
  38. Mathiesen ER , Hommel E , Hansen HP , et al.   Randomized controlled trial of long term efficacy of captopril and preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria . Circulation . 1999;319:24–25
  39. Lurbe E , Redon J , Kesani A , et al.   Increase in nocturnal blood pressure and progresssion to microalbuminuria in type 1 diabetes . N Engl J Med . 2002;347:797–805
  40. MA Collaborative Study Group . Predictors of the development of MA in patients with type 1 diabetes mellitus (A 7 year prospective study) . Diabetes Med . 1991;16:918–925
  41. Poulsen PL , Ebbehoj E , Hansen KW , et al.   24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients . Diabetologia . 1997;40:718–725
  42. Norgaard K , Feldt-Rasmussen B , Borch-Johnsen K , et al.   Prevalance of hypertension in type 1 (insulin dependent) diabetes mellitus . Diabetologia . 1990;33:407–410
  43. Hansen HP , Rossing P , Tarnow L , et al.   Circadian rhythm of arterial pressure and albuminuria in diabetic nephropathy . Kidney Int . 1996;50:579–585
  44. Lafferty AR , Werther GA , Clarke CF . Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type I diabetes . Diabetes Care . 2000;23:989–993
  45. Lurbe A , Redon J , Pascual JM , et al.   Altered blood pressure during sleep in normotensive subjects with type I diabetes . Hypertension . 1993;21:227–235
  46. Moore WV , Donaldson DL , Chonko AM , et al.   Ambulatory blood pressure in type I diabetes mellitus (comparison to presence of incipient nephropathy in adolescents and young adults) . Diabetes . 1992;41:1035–1041
  47. Pecis M , Azevedo MJ , Moraes RS , et al.   Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type I diabetic patients . Diabetes Care . 2000;23:989–993
  48. Spallone V , Gambardella S , Maiello M , et al.   Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients . Diabetes Care . 1994;17:578–584
  49. Voros P , Lengyel Z , Nagy V , et al.   Diurnal blood pressure variation and albuminuria in normotensive patients with insulin-dependent diabetes mellitus . Nephrol Dial Transplant . 1998;13:2257–2260
  50. Farmer C , Goldsmith D , Quin D , et al.   Progression of diabetic nephropathy—Iis diurnal blood pressure rhythm as important as absolute blood pressure level? . Nephrol Dial Transplant . 1998;13:635–639
  51. Nielsen FS , Rossing P , Bang LE , et al.   On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy . Diabetes . 1995;44:783–789
  52. Palatini P , Penzo M , Racioppa A , et al.   Clinical relevance of nighttime blood pressure and of daytime blood pressure variability . Arch Intern Med . 1992;152:1855–1860
  53. Verdecchia P , Schillaci G , Guerrieri M , et al.   Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension . Circulation . 1990;81:528–536
  54. Hogan D , Lurbe A , Salabat R , et al.   Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients . Current Diabetes Rep . 2002;2:539–544
  55. Chaturvedi N , Sjolie A , Stevenson J , et al.   Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes . Lancet . 1993;351:1456–1462
  56. Fava S , Azzopardi J , Ellard S , et al.   ACE gene polymorphism as a prognostic indicator in renal patients with type 2 diabetes and established renal disease . Diabetes Care . 2001;24:2115–2120
  57. Bjorck S , Blohme G , Sylven C , et al.   Deletion/insertion polymorphism of the ACE gene and progression of diabetic nephropathy . Nephrol Dial Transplant . 1997;12:67–70
  58. Fujisawa T , Ikegami H , Kawaguchi Y , et al.   Meta-analysis of association of insertion/deletion polymorphism of angiotensin-I-converting enzyme gene with diabetic nephropathy and retinopathy . Diabetologia . 1998;41:47–53
  59. Wong T , Chan J , Poon E , et al.   Lack of association of angiotensin-I-converting enzyme (DD/II) and angiotensinogen M235 T gene polymorphism with renal function among Chinese patients with type 2 diabetes . Am J Kidney Dis . 1999;33:1064–1070
  60. Yoshida H , Kon V , Ichikawa I . Polymorphisms of the renin-angiotensin system genes in progressive renal diseases . Kidney Int . 1996;50:732–744
  61. Schmidt S , Strojek K , Grzeszczak W , et al.   Excess of DD homozygotes patients in type II diabetes . Nephrol Dial Transplant . 1997;12:427–429
  62. Parving HH , Jacobsen P , Tarnow L , et al.   Effect of deletion polymorphism of angiotensin-converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin-converting enzyme (Observational follow up study) . BMJ . 1996;313:591–594
  63. Marre M , Jeunemaitre X , Gallois Y . Contribution of genetic polymorphism in the renin- angiotensin system to the development of renal complications in insulin dependent diabetes . J Clin Invest . 1997;99:1585–1595
  64. Arzu Ergen H , Hatemi H , Agachan B , et al.   Angiotensin-I-converting enzyme gene polymorphism Turkish type 2 diabetic patients . Exp Mol Med . 2004;36:345–350
  65. Jacobsen P , Tarnow L , Carstensen B , et al.   Genetic variation in the renin angiotensin system and progression of diabetic nephropathy . J Am Soc Nephrol . 2003;14:2843–2850
  66. Cosmo S , Miscio G , Zucaro L , et al.   The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients (Evidence for a polygenic control of kidney disease progression) . Nephrol Dial Transplant . 2002;17:1402–1407
  67. Hadjadj S , Belloum R , Bouhanick B , et al.   Prognostic value of angiotensin I-converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus (A prospective study) . J Am Soc Nephrol . 2001;12: 541–519
  68. Ittersum F , Man A , Tyssen S , et al.   Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus . Nephrol Dialy Transplant . 2000;15:1000–1007
  69. Tarnow L , Gluud C , Parving HH . Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-I-converting enzyme gene . Nephrol Dial Transplant . 1998;13:1125–1130
  70. Kajantie E , Rautanen A , Kere J , et al.   The effects of the ACE gene insertion/deletion polymorphism on glucose tolerance and insulin secretion in elderly people are modified by birth weight . J Clin Endocrinol Metab . 2004;111:5738–5741
  71. Rigat B , Hubert C , Alhenc-Gelas F , et al.   An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels . J Clin Invest . 1990;86:1343–1346
  72. Pueyo M , Ghallah M , Gauguier D , et al.   Transforming growth factor-B1 production is correlated with genetically determined ACE expression in congenic rats . Diabetes . 2004;53:1111–1118
  73. Ye M , Wysocki J , Naaz P , et al.   Increased ACE2 and decreased ACE protein in renal tubules from diabetic mice (A renoprotective combination?) . Hypertension . 2004;43:1120–1125
  74. Solini A , Vestra M , Saller A , et al.   The angiotensin-I-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes . Diabetes . 2002;51:251–255
  75. Tarnow L , Cambien F , Rossing P , et al.   Lack of relationship between insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients . Diabetes . 1995;44:489–494
  76. Penno G , Chaturvedi N , Talmud P , et al.   Effect of angiotensin converting enzyme gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients (Finds from the EUCLID randomized controlled trial) . Diabetes . 1998;41:1507–1511

PII: S1548-5595(05)00036-4

doi: 10.1053/j.ackd.2005.02.001

Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 202-211 , April 2005

Article Tools

* Image Usage & Resolution